Compounds > haloperidol

haloperidol and 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone

haloperidol has been researched along with 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rasmussen, K1

Reviews

1 review(s) available for haloperidol and 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone

ArticleYear
CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons.
    Annals of the New York Academy of Sciences, 1994, Mar-23, Volume: 713

    Topics: Animals; Anxiety; Brain; Cholecystokinin; Dopamine; Haloperidol; Humans; Neurons; Pyrazoles; Receptors, Cholecystokinin; Schizophrenia

1994